Novo Nordisk A/S (NOVOB.C.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NOVOB.C.DX | ||||
| Company | Novo Nordisk A/S | ||||
| Price Information | |||||
| Exchange | DXE | ||||
| Open | 257.550 | ||||
| High | 262.100 | ||||
| Low | 254.200 | ||||
| Latest | 260.400 | ||||
| Change | +4.100 | ||||
| % Change | +1.60% | ||||
| Volume | 1,789,382 | ||||
| 20-Day Average Volume | 2,868,417 | ||||
| Previous Close | 256.300 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 239.893 | ||||
| 20-Day Raw Stochastic | 89.47% | ||||
| 20-Day Relative Strength | 52.05 | ||||
| Weighted Alpha | -28.46 | ||||
| Today's Opinion | 56% Sell | ||||
| Previous Opinion | 80% Sell | ||||
| Last Month's Opinion | 88% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.24% since 04/10/26 | ||||
| Low | 235.950 on 04/13/26 | ||||
| High | 264.450 on 04/16/26 | ||||
| 1-Month | |||||
| %Chg | +4.32% since 03/17/26 | ||||
| Low | 226.000 on 03/27/26 | ||||
| High | 264.450 on 04/16/26 | ||||
| 3-Month | |||||
| %Chg | -32.66% since 01/16/26 | ||||
| Low | 226.000 on 03/27/26 | ||||
| High | 410.000 on 01/23/26 | ||||
| 6-Month | |||||
| %Chg | -24.25% since 10/17/25 | ||||
| Low | 226.000 on 03/27/26 | ||||
| High | 410.000 on 01/23/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 0 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||